Targeting cancer cells by cutting off essential nutrients and backup supplies

Breast Cancer News

Targeting cancer cells by cutting off essential nutrients and backup supplies
CancerColdDiet
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 33 sec. here
  • 10 min. at publisher
  • 📊 Quality Score:
  • News: 45%
  • Publisher: 71%

Cancer cells have voracious appetites. And there are certain nutrients they can't live without. Scientists have long hoped they might stop tumors in their tracks by cutting off an essential part of cancer cells' diet.

Cold Spring Harbor Laboratory Aug 28 2024 Cancer cells have voracious appetites. And there are certain nutrients they can't live without. Scientists have long hoped they might stop tumors in their tracks by cutting off an essential part of cancer cells' diet. But these cells are crafty and often find a new way to get what they need. How? By reprogramming their metabolism and switching to backup food supplies.

How does this work? Let's go back to cancer metabolism. Aggressive cancer cells avidly consume an amino acid called glutamine. They use this vital nutrient to generate the energy and materials needed to grow and replicate. Lukey and postdoc Yijian Qiu saw the same thing in their lab. They noticed that breast cancer cells adapt to glutamine starvation by switching on a pathway that generates a critical metabolite called alpha-ketoglutarate, normally derived from glutamine. This enables cancer cells to continue producing the energy and building materials they would otherwise get from glutamine. It was a lightbulb moment for Lukey's lab.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

NewsMedical /  🏆 19. in UK

Cancer Cold Diet Enzyme Glutamine Laboratory Metabolism Nutrients

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

New hope in cancer treatment: Targeting Tpex cellsNew hope in cancer treatment: Targeting Tpex cellsTumor immunotherapy leverages the body's immune system to target and eradicate cancer cells, offering a crucial treatment for patients unresponsive to surgery or conventional therapies.
Read more »

Scientists unravel how the BCG vaccine leads to the destruction of bladder cancer cellsScientists unravel how the BCG vaccine leads to the destruction of bladder cancer cellsUsing zebrafish 'avatars,' an animal model developed by the Cancer Development and Innate Immune Evasion lab at the Champalimaud Foundation (CF), led by Rita Fior, Mayra Martínez-López—a former Ph.D.
Read more »

Scientists find way to starve breast cancer cellsScientists find way to starve breast cancer cellsCancer cells have voracious appetites. And there are certain nutrients they can't live without. Scientists have long hoped they might stop tumors in their tracks by cutting off an essential part of cancer cells' diet. But these cells are crafty and often find a new way to get what they need.
Read more »

Targeting oncogenic transcription factors to develop potential new cancer treatmentsTargeting oncogenic transcription factors to develop potential new cancer treatmentsA new study from the University of Michigan Health Rogel Cancer Center furthers research that suggests the potential of developing new cancer treatments to target oncogenic transcription factors by indirectly affecting their ability to access enhancer DNA in chromatin.
Read more »

FDA approves drug targeting brain cancer gene mutationFDA approves drug targeting brain cancer gene mutationA new drug for treatment of a type of brain cancer, called IDH-mutant low-grade glioma, was approved Aug. 6 by the U.S. Food and Drug Administration (FDA). The promising new drug stems from a 2008 genetic discovery made at the Johns Hopkins Kimmel Cancer Center.
Read more »

New directions in targeting the multifaceted BRAF in cancerNew directions in targeting the multifaceted BRAF in cancerA new research perspective titled 'Targeting the multifaceted BRAF in cancer: New directions' has been published in Oncotarget.
Read more »



Render Time: 2025-02-15 08:34:05